Pseudomonas aeruginosa exoenzyme S stimulates murine lymphocyte proliferation in vitro

Infection and Immunity

Volumn 67, Issue 9, 1999, Pages 4613-4619

  Barclay, Neil G ^a   Spurrell, Jason C L ^a   Bruno, Tony F ^a   Storey, Douglas G ^a   Woods, Donald E ^a   Mody, Christopher H ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; EXOENZYME S; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CYSTIC FIBROSIS; GENETIC VARIABILITY; GRAM NEGATIVE INFECTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

EID: 0032805052     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.9.4613-4619.1999     Document Type: Article

References (38)

1. Bach, M., and A. Hoffenbach. 1987. Strain-dependent protective effect of adult thymectomy on murine infection by Mycobacterium lepraemurium. Clin. Exp. Immunol. 68:521-527.
2. Boat, T. F., M. J. Welsh, and A. L. Beaudet. 1989. Cystic fibrosis, p. 2649-2680. In C. R. Scriver, A. L. Beadet, W. S. Sly, and D. Valle (ed.), The metabolic basis of inherited disease. McGraw-Hill, New York, N.Y.
3. Boom, W. H., L. Liebster, A. K. Abbas, and R. G. Titus. 1990. Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect. Immun. 58:3863-3870.
4. Bruno, T. F., R. M. Syme, D. E. Buser, D. E. Woods, and C. H. Mody. 1998. Pseudomonas aeruginosa exoenzyme S is a mitogen, but not a superantigen for adult T lymphocytes. Infect. Immun. 66:3072-3079.
5. Bruno, T. F., D. E. Woods, and C. H. Mody. 1999. Recombinant Pseudomonas exoenzyme S and exoenzyme S from Pseudomonas aeruginosa strain DG1 stimulate T lymphocytes to proliferate. Can. J. Microbiol.45:1-5..
6. Chartrand, S. A., and M. I. Marks. 1983. Pulmonary infections in cystic fibrosis: pathogenesis and therapy, p. 201-214. In J. E. Pennington (ed.), Respiratory infections: diagnosis and management. Raven Press, New York, N.Y.
7. Fiel, S. B. 1993. Clinical management of pulmonary disease in cystic fibrosis. Lancet 341:1070-1074.
8. Frithz-Lindsten, E., Y. Du, R. Rosqvist, and A. Forsberg. 1997. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via a type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments. Mol. Microbiol. 25:1125-1139.
9. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4:35-51.
10. Goranson, J., and D. W. Frank. 1996. Genetic analysis of exoenzyme S by Pseudomonas aeruginosa. FEMS Microbiol. Lett. 135:149-155.
11. Gosselin, D., J. DeSanctis, M. Boule, E. Skamene, C. Matouk, and D. Radzioch. 1995. Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect. Immun. 63:3272-3278.
12. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59-72.
13. Iglewski, B. H., J. C. Sadoff, M. J. Bjorn, and E. S. Maxwell. 1978. Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A. Proc. Natl. Acad. Sci. USA 75:3211-3215.
14. Jupin, C., S. Anderson, C. Damais, J. E. Alouf, and M. Parant. 1988. Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and g-interferon. J. Exp. Med. 167:752-761.
15. Knight, D. A., V. Finck-Babancon, S. M. Kulich, and J. T. Barbieri. 1995. Functional domains of Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 63:3182-3186.
16. Kudoh, I., J. P. Wiener-Kronish, S. Hashimoto, J. Pittet, and D. W. Frank. 1994. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am. J. Physiol. 267:L551-L556.
17. Kulich, S., D. W. Frank, and J. T. Barbieri. 1995. Expression of recombinant exoenzyme S of Pseudomonas aeruginosa. Infect. Immun. 63:1-8.
18. Locksley, R. M., F. P. Heinzel, M. D. Sadick, B. J. Holaday, and K. D. Gardner. 1987. Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets. Ann. Inst. Pasteur/Immunol. 138:744-749.
19. Marrack, P., M. Blackman, E. Kushnir, and J. Kappler. 1990. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med. 171:455-464.
20. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. Wagner. 1992. T cell mediated lethal shock triggered in mice by the super-antigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175:91-98.
21. Mody, C. H., D. E. Buser, R. M. Syme, and D. E. Woods. 1995. Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes. Infect. Immun. 63:1800-1805.
22. Moore, J. 1995. A simplified method for the coordinate examination of apoptosis and the surface phenotype of murine lymphocytes. J. Immunol. Methods 188:219-228.
23. Morissette, C., E. Skamene, and F. Gervais. 1995. Endobronchial inflammation following Pseudomonas aeruginosa infection in resistant and susceptible strains of mice. Infect. Immun. 63:1718-1724.
24. Nicas, T. I., J. Bradley, J. E. Lochner, and B. H. Iglewski. 1985. The role of exoenzyme S in infections with Pseudomonas aeruginosa. J. Infect. Dis. 152: 716-721.
25. Nicas, T. I., D. W. Frank, P. Stenzel, J. D. Lile, and B. H. Iglewski. 1985. Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections. Eur. J. Clin. Microbiol. 4:175-179.
26. Pier, G. B., R. B. Markham, and D. Eardley. 1981. Correlation of the biologic responses of C3H/HeJ mice to endotoxin with the chemical and structural properties of lipopolysaccharides from Pseudomonas aeruginosa and Escherichia coli. J. Immunol. 127:184-191.
27. Pond, L., D. L. Wassom, and C. E. Hayes. 1992. Influence of resistant and susceptible genotype, IL-1, and lymphoid organ on Trichinella spiralis-induced cytokine secretion. J. Immunol. 149:957-965.
28. Rose, J. R., W. J. Christ, J. R. Bristol, T. Kawata, and D. P. Rossignol. 1995. Agonistic and antagonistic activities of barterially derived Rhodobacter sphaeroides lipid A: comparison with activities of synthetic material of the proposed structure and analogs. Infect. Immun. 63:833-839.
29. Rozmahel, R., M. Wilschanski, A. Matin, S. Plyte, M. Oliver, W. Auerbach, A. Moore, J. Forstner, P. Durie, J. Nadeau, C. Bear, and L. C. Tsui. 1996. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat. Genet. 12:280-287.
30. Sadick, M. D., R. M. Locksley, C. Tubbs, and H. V. Raff. 1986. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. J. Immunol. 136:655-661.
31. Snouwaert, J. N., K. K. Brigman, A. M. Latour, N. N. Malouf, R. C. Boucher, O. Smithies, and B. H. Koller. 1992. An animal model for cystic fibrosis made by gene targeting. Science 257:1083-1088.
32. Stevenson, M. M., T. K. Kondratieva, A. S. Apt, M. F. Tam, and E. Skamene. 1995. In vitro and in vivo T cell responses in mice during bronchopulmonary infection with mucoid Pseudomonas aeruginosa. Clin. Exp. Immunol. 99:98-105.
33. Taylor-Robinson, A. W., R. S. Phillips, A. Severn, S. Moncada, and F. Y. Liew. 1993. The role of TH1 and TH2 cells in rodent malaria infection. Science 260:1931-1934.
34. Wiener-Kronish, J. P., T. Sakuma, I. Kudoh, J. F. Pittet, D. Frank, L. Dobbs, M. L. Vasil, and M. A. Matthay. 1993. Alveolar epithelial injury and pleural empyema in acute Pseudomonas aeruginosa pneumonia in anesthetized rabbits. J. Appl. Physiol. 75:1661-1669.
35. Woods, D. E., W. S. Hwang, M. S. Shahrabadi, and J. U. Que. 1988. Alteration of pulmonary structure by Pseudomonas aeruginosa exoenzyme S. J. Med. Microbiol. 26:133-141.
36. Woods, D. E., J. S. Lam, W. Paranchych, D. P. Speert, M. Campbell, and A. J. Godfrey. 1997. Correlation of Pseudomonas aeruginosa virulence factors from clinical and environmental isolates with pathogenicity in the neutropenic mouse. Can. J. Microbiol. 43:541-551.
37. Woods, D. E., and J. U. Que. 1987. Purification of Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 55:579-586.
38. Woods, D. E., and P. A. Sokol. 1985. Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. 4:163-169.